These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 26142737)

  • 21. The number of polyploid giant cancer cells and epithelial-mesenchymal transition-related proteins are associated with invasion and metastasis in human breast cancer.
    Fei F; Zhang D; Yang Z; Wang S; Wang X; Wu Z; Wu Q; Zhang S
    J Exp Clin Cancer Res; 2015 Dec; 34():158. PubMed ID: 26702618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Androgen and androgen-metabolizing enzymes in metastasized lymph nodes of breast cancer.
    Shibahara Y; Miki Y; Sakurada C; Uchida K; Hata S; McNamara K; Yoda T; Takagi K; Nakamura Y; Suzuki T; Ishida T; Ohuchi N; Sasano H
    Hum Pathol; 2013 Oct; 44(10):2338-45. PubMed ID: 23953348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene expression profile of normal and cancer-associated fibroblasts according to intratumoral inflammatory cells phenotype from breast cancer tissue.
    González L; Eiro N; Fernandez-Garcia B; González LO; Dominguez F; Vizoso FJ
    Mol Carcinog; 2016 Nov; 55(11):1489-1502. PubMed ID: 26349857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of chemotactic factor receptor 5 gene with breast cancer.
    Zhang Y; Meng FY; Li WL; Zhou CX; Guan Z; Fan HY
    Genet Mol Res; 2013 Nov; 12(4):5289-300. PubMed ID: 24301790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Balanced Tiam1-rac1 and RhoA drives proliferation and invasion of pancreatic cancer cells.
    Guo X; Wang M; Jiang J; Xie C; Peng F; Li X; Tian R; Qin R
    Mol Cancer Res; 2013 Mar; 11(3):230-9. PubMed ID: 23322732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
    Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
    Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
    Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting sentinel lymph node metastases in infiltrating breast carcinoma with vascular invasion.
    Jonjic N; Mustac E; Dekanic A; Marijic B; Gaspar B; Kolic I; Coklo M; Sasso F
    Int J Surg Pathol; 2006 Oct; 14(4):306-11. PubMed ID: 17041193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of Bcl-2 and p53 expression in primary breast tumors and corresponding metastatic lymph nodes.
    Arun B; Kilic G; Yen C; Foster B; Yardley D; Gaynor R; Ashfaq R
    Cancer; 2003 Dec; 98(12):2554-9. PubMed ID: 14669273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential Expression of RAGE, EGFR and Ki-67 in Primary Tumors and Lymph Node Deposits of Breast Carcinoma.
    Aboushousha T; Hammam O; Safwat G; Eesa A; Ahmed S; Esmat ME; Helmy AH
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2269-2277. PubMed ID: 30139236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of programmed cell death protein 1 (PD-1) and indoleamine 2,3-dioxygenase (IDO) in the tumor microenvironment and in tumor-draining lymph nodes of breast cancer.
    Ye Q; Wang C; Xian J; Zhang M; Cao Y; Cao Y
    Hum Pathol; 2018 May; 75():81-90. PubMed ID: 29447919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted proteomics driven verification of biomarker candidates associated with breast cancer aggressiveness.
    Procházková I; Lenčo J; Fučíková A; Dresler J; Čápková L; Hrstka R; Nenutil R; Bouchal P
    Biochim Biophys Acta Proteins Proteom; 2017 May; 1865(5):488-498. PubMed ID: 28216224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Podoplanin increases the migration of human fibroblasts and affects the endothelial cell network formation: A possible role for cancer-associated fibroblasts in breast cancer progression.
    Suchanski J; Tejchman A; Zacharski M; Piotrowska A; Grzegrzolka J; Chodaczek G; Nowinska K; Rys J; Dziegiel P; Kieda C; Ugorski M
    PLoS One; 2017; 12(9):e0184970. PubMed ID: 28938000
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of the RAC1, RHOA and CXCR4 proteins and their interaction as risk factors for infiltration to the nipple areola complex in operable breast carcinoma.
    Heriady Y; Achmad D; Hernowo BS; Faried A; Ismono D; Hilmanto D
    Breast Cancer; 2019 Mar; 26(2):172-179. PubMed ID: 30209686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors predicting non-sentinel lymph node involvement in sentinel node positive breast carcinoma.
    Durak MG; Akansu B; Akin MM; Sevınç AI; Koçdor MA; Saydam S; Harmancioğlu O; Ellıdokuz H; Bekış R; Canda T
    Turk Patoloji Derg; 2011; 27(3):189-95. PubMed ID: 21935867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does analysis of biomarkers in tumor cells in lymph node metastases give additional prognostic information in primary breast cancer?
    Falck AK; Fernö M; Bendahl PO; Rydén L
    World J Surg; 2010 Jul; 34(7):1434-41. PubMed ID: 20213203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-146a inhibits cell migration and invasion by targeting RhoA in breast cancer.
    Liu Q; Wang W; Yang X; Zhao D; Li F; Wang H
    Oncol Rep; 2016 Jul; 36(1):189-96. PubMed ID: 27175941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced RhoA expression enhances breast cancer metastasis with a concomitant increase in CCR5 and CXCR4 chemokines signaling.
    Kalpana G; Figy C; Yeung M; Yeung KC
    Sci Rep; 2019 Nov; 9(1):16351. PubMed ID: 31705019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinicopathological significance of CD44+/CD24-/low and CD24+ tumor cells in invasive micropapillary carcinoma of the breast.
    Li W; Liu F; Lei T; Xu X; Liu B; Cui L; Wei J; Guo X; Lang R; Fan Y; Gu F; Tang P; Zhang X; Fu L
    Pathol Res Pract; 2010 Dec; 206(12):828-34. PubMed ID: 20977976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.